[go: up one dir, main page]

NO20003096D0 - Sammensetninger og fremgangsmÕter for behandling av ADD - Google Patents

Sammensetninger og fremgangsmÕter for behandling av ADD

Info

Publication number
NO20003096D0
NO20003096D0 NO20003096A NO20003096A NO20003096D0 NO 20003096 D0 NO20003096 D0 NO 20003096D0 NO 20003096 A NO20003096 A NO 20003096A NO 20003096 A NO20003096 A NO 20003096A NO 20003096 D0 NO20003096 D0 NO 20003096D0
Authority
NO
Norway
Prior art keywords
compositions
methods
treating add
treating
add
Prior art date
Application number
NO20003096A
Other languages
English (en)
Other versions
NO20003096L (no
NO329974B1 (no
Inventor
Juan Mantelle
Terese A Dixon
Original Assignee
Noven Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26750154&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20003096(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Noven Pharma filed Critical Noven Pharma
Publication of NO20003096D0 publication Critical patent/NO20003096D0/no
Publication of NO20003096L publication Critical patent/NO20003096L/no
Publication of NO329974B1 publication Critical patent/NO329974B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
NO20003096A 1997-12-15 2000-06-15 Sammensetning for topisk applikasjon av metylfenidat, og anvendelse av metylfenidat i fremstillingen av et fleksibelt, endelig system for behandling av ADHD og ADD. NO329974B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6951097P 1997-12-15 1997-12-15
US09/163,351 US6210705B1 (en) 1997-12-15 1998-09-30 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
PCT/US1998/026560 WO1999030694A2 (en) 1997-12-15 1998-12-14 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate

Publications (3)

Publication Number Publication Date
NO20003096D0 true NO20003096D0 (no) 2000-06-15
NO20003096L NO20003096L (no) 2000-08-15
NO329974B1 NO329974B1 (no) 2011-01-31

Family

ID=26750154

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003096A NO329974B1 (no) 1997-12-15 2000-06-15 Sammensetning for topisk applikasjon av metylfenidat, og anvendelse av metylfenidat i fremstillingen av et fleksibelt, endelig system for behandling av ADHD og ADD.

Country Status (28)

Country Link
US (2) US6210705B1 (no)
EP (2) EP1037615B1 (no)
JP (3) JP4316800B2 (no)
KR (1) KR100633348B1 (no)
CN (1) CN1368876A (no)
AR (1) AR014062A1 (no)
AT (1) ATE260652T1 (no)
AU (1) AU752027B2 (no)
BR (1) BR9814282A (no)
CA (1) CA2315237C (no)
CZ (2) CZ305817B6 (no)
DE (1) DE69822199T2 (no)
DK (1) DK1037615T3 (no)
ES (2) ES2452517T3 (no)
HK (1) HK1049447A1 (no)
HU (1) HU226615B1 (no)
IL (1) IL136760A0 (no)
LV (1) LV12558B (no)
NO (1) NO329974B1 (no)
NZ (1) NZ505689A (no)
PE (1) PE20000120A1 (no)
PL (1) PL195315B1 (no)
PT (1) PT1037615E (no)
RU (1) RU2233156C2 (no)
SI (1) SI20360B (no)
TR (1) TR200001736T2 (no)
TW (2) TWI244396B (no)
WO (1) WO1999030694A2 (no)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US20020102291A1 (en) * 1997-12-15 2002-08-01 Noven Pharmaceuticals, Inc. Compositions and method for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
GB9913458D0 (en) * 1999-06-09 1999-08-11 Medeva Europ Ltd The therapeutic use of d-threo-methylphenidate
GB9918735D0 (en) * 1999-08-09 1999-10-13 Straken Limited Transdermal patches
CO5261532A1 (es) * 1999-11-15 2003-03-31 Novartis Ag Compuestos heterociclicos sililados, procedimiento para la preparacion de estos y composicion farmaceutica que los contiene
US7384959B2 (en) * 1999-12-17 2008-06-10 Celltech Pharma Europe Limited Treatment of convulsive states
US6455066B1 (en) 2000-03-10 2002-09-24 Epicept Corporation Intradermal-penetration agents for topical local anesthetic administration
US6905016B2 (en) * 2000-03-14 2005-06-14 Noven Pharmaceuticals, Inc. Packaging system for transdermal drug delivery systems
US7674480B2 (en) * 2000-06-23 2010-03-09 Teva Pharmaceutical Industries Ltd. Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
US20020119187A1 (en) * 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
DE10060550C1 (de) * 2000-12-06 2002-04-18 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Oxybutynin und Verfahren zur Herstellung Oxybutynin enthaltender Wirkstoffschichten
US7988991B2 (en) * 2001-03-07 2011-08-02 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch
FR2822049B1 (fr) * 2001-03-13 2003-08-01 Dbv Medica 1 Patch destine notamment a depister l'etat de sensibilisation d'un sujet a un allergene, procede de fabrication et utilisation
CN101524339A (zh) * 2001-03-16 2009-09-09 阿尔扎公司 施用芬太尼的经皮贴剂
US20050208117A1 (en) * 2001-03-16 2005-09-22 Venkatraman Subramanian S Transdermal administration of fentanyl and analogs thereof
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
DE10141652B4 (de) * 2001-08-24 2011-04-07 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung
US20030049272A1 (en) * 2001-08-30 2003-03-13 Yatindra Joshi Pharmaceutical composition which produces irritation
JP4354678B2 (ja) * 2002-08-28 2009-10-28 久光製薬株式会社 貼付剤
US6913768B2 (en) 2002-09-24 2005-07-05 Shire Laboratories, Inc. Sustained release delivery of amphetamine salts
CN101797221B (zh) 2002-12-13 2013-06-12 杜雷科特公司 包含高粘度液体载体材料的口服递药系统
ME00114B (me) * 2003-10-28 2011-02-10 Noven Pharma Kompozicije i postupci za kontrolisanje gubitka i oslobađanja lijeka u transdermalnim sistemima oslobađanja lijeka
CA2595400C (en) * 2005-01-20 2017-01-17 Institute For Molecular Medicine, Inc. Methylphenidate derivatives and their use in the treatment of angiogenic diseases and conditions
US20060183773A1 (en) * 2005-01-20 2006-08-17 David Bar-Or Uses of methylphenidate derivatives
EP1962815B1 (de) * 2005-12-23 2010-08-11 Epinamics GmbH Verwendung filmbildender haarpflegepolymere aus der gruppe der polyurethane und diese polymere enthaltende pharmazeutische zubereitungen und pflaster
US9393218B2 (en) * 2005-12-23 2016-07-19 Epinamics Gmbh Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches that contain these polymers
MX2008010934A (es) * 2006-02-27 2008-10-30 Noven Pharma Sistema terapeutico transdermico que contiene escopolamina.
US8568695B2 (en) * 2006-05-01 2013-10-29 Colgate-Palmolive Company Oral care composition with silicone composite
CA2678806C (en) * 2007-02-21 2017-05-16 Connected Health Systems, Llc Treating adhd and other diseases involving inflammation
MY154027A (en) * 2007-10-15 2015-04-30 Alza Corp Once-a-day replacement transdermal administration of fentanyl
FR2924350B1 (fr) * 2007-12-03 2010-08-13 Dbv Tech Procede et compositions pour la vaccination par voie cutanee
FR2924349B1 (fr) 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
AU2008335809A1 (en) 2007-12-06 2009-06-18 Durect Corporation Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
ES2524696T3 (es) * 2007-12-31 2014-12-11 Acclarent, Inc. Vendaje del tejido de la mucosa y método de uso
FR2926466B1 (fr) * 2008-01-23 2010-11-12 Dbv Tech Procede de fabrication de patchs par electrospray
EP2300011A4 (en) 2008-05-27 2012-06-20 Dmi Life Sciences Inc THERAPEUTIC PROCESSES AND COMPOUNDS
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
JP5155128B2 (ja) * 2008-12-11 2013-02-27 日東電工株式会社 メチルフェニデート貼付製剤
EP2942196B8 (en) * 2009-06-05 2018-01-10 Babcock & Wilcox MEGTEC, LLC Improved infrared float bar
EP2364695A1 (en) 2010-02-10 2011-09-14 Nitto Denko Corporation Methylphenidate patch preparation
US20110200663A1 (en) * 2010-02-12 2011-08-18 Nitto Denko Corporation Methylphenidate patch preparation
US9283214B2 (en) 2011-03-23 2016-03-15 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US10292937B2 (en) 2011-03-23 2019-05-21 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US8927010B2 (en) 2011-03-23 2015-01-06 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US11241391B2 (en) 2011-03-23 2022-02-08 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
PT2688557T (pt) 2011-03-23 2017-11-23 Ironshore Pharmaceuticals & Dev Inc Métodos e composições para o tratamento de distúrbio de défice de atenção
US9498447B2 (en) 2011-03-23 2016-11-22 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9119809B2 (en) 2011-03-23 2015-09-01 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US10905652B2 (en) 2011-03-23 2021-02-02 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9603809B2 (en) 2011-03-23 2017-03-28 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US8916588B2 (en) 2011-03-23 2014-12-23 Ironshore Pharmaceuticals & Development, Inc. Methods for treatment of attention deficit hyperactivity disorder
CN107261148B (zh) * 2011-07-28 2021-07-13 凯姆制药公司 哌甲酯前药、其制备和使用方法
US9717697B2 (en) 2012-10-15 2017-08-01 Noven Pharmaceuticals, Inc. Compositions and methods for the transdermal delivery of methylphenidate
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
WO2014106014A1 (en) 2012-12-28 2014-07-03 Noven Pharmaceuticals, Inc Transdermal drug delivery systems for levonorgestrel and ethinyl estradiol
MX366230B (es) 2012-12-28 2019-07-03 Noven Pharma Composiciones multipolimericas para liberación transdermica de farmaco.
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics
WO2014159582A1 (en) 2013-03-14 2014-10-02 Noven Pharmaceuticals, Inc Amphetamine transdermal compositions with acrylic block copolymer
WO2014144975A1 (en) 2013-03-15 2014-09-18 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
AR095259A1 (es) 2013-03-15 2015-09-30 Noven Pharma Composiciones y métodos para la administración transdérmica de fármacos de amina terciaria
AR095260A1 (es) 2013-03-15 2015-09-30 Noven Pharma Composiciones de anfetaminas transdérmicas estables y métodos de fabricación
AU2014371437B2 (en) 2013-12-25 2020-01-30 Fujimoto Co., Ltd. Prophylactic and therapeutic agent for attention-deficit/hyperactivity disorder
US9980921B2 (en) * 2016-06-30 2018-05-29 Taho Pharmaceuticals Ltd. Transdermal delivery system containing methylphenidate or its salts and methods thereof
CA3028450A1 (en) 2016-07-06 2018-01-11 Durect Corporation Oral dosage form with drug composition, barrier layer and drug layer
CN106511264A (zh) * 2016-11-15 2017-03-22 北京万全德众医药生物技术有限公司 一种盐酸哌甲酯口服溶液剂及其制备方法
HUE067004T2 (hu) 2016-12-11 2024-10-28 Zevra Therapeutics Inc Metilfenidát prodrogokat tartalmazó készítmények, eljárások azok elõállítására és felhasználására
EP3598982A1 (en) 2018-07-23 2020-01-29 Centre National De La Recherche Scientifique Bioconjugates of neuropeptides derivatives
JP7600661B2 (ja) * 2020-12-11 2024-12-17 ａｒｔｉｅｎｃｅ株式会社 貼付剤

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2957880A (en) 1953-12-23 1960-10-25 Ciba Pharm Prod Inc Process for the conversion of stereoisomers
US4310509A (en) 1979-07-31 1982-01-12 Minnesota Mining And Manufacturing Company Pressure-sensitive adhesive having a broad spectrum antimicrobial therein
US4655767A (en) 1984-10-29 1987-04-07 Dow Corning Corporation Transdermal drug delivery devices with amine-resistant silicone adhesives
US5474783A (en) 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5656286A (en) 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
DE3910578A1 (de) * 1989-03-29 1990-10-04 Schering Ag Mittel zur transdermalen applikation enthaltend gestoden
JP2693212B2 (ja) * 1989-03-28 1997-12-24 日東電工株式会社 疾患治療用テープ製剤
WO1992021333A2 (en) * 1991-05-24 1992-12-10 Pharmavene, Inc. Treatment of drug withdrawal symptoms and drug craving with type b monoamine oxidase inhibitors
US5629019A (en) 1992-02-27 1997-05-13 Alza Corporation Formulations with hydrophobic permeation enhancers
ATE152630T1 (de) 1992-07-28 1997-05-15 Procter & Gamble Pharmazeutische zusammensetzung zur topischen anwendung die ein vernetztes kationisches polymer und einen alkoxylierte äther enthält
CH691209A5 (de) 1993-09-06 2001-05-15 Scherrer Inst Paul Herstellungsverfahren für einen Polmerelektrolyten und elektrochemische Zelle mit diesem Polymerelektrolyten.
EP0689920B1 (de) 1994-06-29 1999-10-13 Hennecke GmbH Verfahren und Vorrichtung zum kontinuierlichen Herstellen von Schaumstoffblöcken oder Schaumstoffbahnen
US5601839A (en) 1995-04-26 1997-02-11 Theratech, Inc. Triacetin as a penetration enhancer for transdermal delivery of a basic drug
US5780050A (en) 1995-07-20 1998-07-14 Theratech, Inc. Drug delivery compositions for improved stability of steroids
AU2590697A (en) 1997-03-07 1998-09-22 Richard R. Jackson Anesthetizing plastics, drug delivery plastics, and related medical products, s ystems and methods
GB9711032D0 (en) 1997-05-30 1997-07-23 Johnson Matthey Plc Compound as a stimulant for the central nervous system
EP1710506A2 (en) 1999-12-15 2006-10-11 Osaka Gas Co., Ltd. Burner Apparatus, Gas Turbine Engine and Cogeneration System

Also Published As

Publication number Publication date
KR100633348B1 (ko) 2006-10-16
BR9814282A (pt) 2000-10-03
RU2233156C2 (ru) 2004-07-27
EP1037615B1 (en) 2004-03-03
NZ505689A (en) 2003-01-31
ATE260652T1 (de) 2004-03-15
LV12558A (lv) 2000-11-20
CA2315237C (en) 2009-12-01
LV12558B (en) 2001-03-20
AU752027B2 (en) 2002-09-05
CA2315237A1 (en) 1999-06-24
US6348211B1 (en) 2002-02-19
ES2219926T3 (es) 2004-12-01
EP2314288A1 (en) 2011-04-27
SI20360A (sl) 2001-04-30
NO20003096L (no) 2000-08-15
IL136760A0 (en) 2001-06-14
NO329974B1 (no) 2011-01-31
PE20000120A1 (es) 2000-02-19
EP2314288B1 (en) 2013-12-11
JP2002510600A (ja) 2002-04-09
WO1999030694A3 (en) 1999-08-19
CZ20002209A3 (cs) 2000-11-15
SI20360B (sl) 2008-06-30
TR200001736T2 (tr) 2001-01-22
AR014062A1 (es) 2001-01-31
PL341596A1 (en) 2001-04-23
DE69822199D1 (de) 2004-04-08
TWI242452B (en) 2005-11-01
CZ300535B6 (cs) 2009-06-10
EP1037615A2 (en) 2000-09-27
HK1049447A1 (zh) 2003-05-16
ES2452517T3 (es) 2014-04-01
CN1368876A (zh) 2002-09-11
WO1999030694A2 (en) 1999-06-24
DK1037615T3 (da) 2004-07-12
AU1824999A (en) 1999-07-05
JP2009073856A (ja) 2009-04-09
KR20010033114A (ko) 2001-04-25
JP2013056944A (ja) 2013-03-28
TWI244396B (en) 2005-12-01
CZ2009132A3 (cs) 2016-03-23
HK1156872A1 (en) 2012-06-22
HUP0004539A3 (en) 2006-06-28
PL195315B1 (pl) 2007-08-31
HU226615B1 (en) 2009-04-28
HUP0004539A2 (hu) 2001-06-28
CZ305817B6 (cs) 2016-03-23
TW200406231A (en) 2004-05-01
DE69822199T2 (de) 2005-02-17
US6210705B1 (en) 2001-04-03
JP4316800B2 (ja) 2009-08-19
PT1037615E (pt) 2004-07-30

Similar Documents

Publication Publication Date Title
NO20003096D0 (no) Sammensetninger og fremgangsmÕter for behandling av ADD
NO991676D0 (no) FremgangsmÕter og sammensetninger for immunmodulering
NO20012916D0 (no) Sammensetninger og fremgangsmåter for behandling av anorektale forstyrrelser
DE69834401D1 (de) Businterfacesystem und verfahren
NO994778D0 (no) FremgangsmÕter og sammensetninger for behandling av tarmbetennelse
NO973464D0 (no) Forlengingsrör - avskraperpluggapparat og fremgangsmåte
ATE351910T1 (de) Ob-fusionsprotein enthaltende zusammensetzungen und verfahren
EP1014995A4 (en) COMPOSITIONS AND METHODS FOR PREVENTING RESTENOSES CONSECUTIVE TO REVASCULARIZATION INTERVENTIONS
NO20006488D0 (no) Sammensetning og anvendelse
NO20005017D0 (no) Metoder og viskøse sammensetninger for behandling av brønner
DK1112003T3 (da) Ny sammensætning og anvendelse
DK0804078T3 (da) Sammensætning og anvendelse deraf
PT956294E (pt) Inibidores da trombina
DE69904731D1 (de) Feinzerkleinerer und feinzerkleinerungsverfahren
NO985385L (no) Bitumensammensetninger og fremgangsmÕte for fremstilling derav
ZA981600B (en) Methods and compositions for treating stickies
NO996090D0 (no) Forbedret foskefor og fremgangsmåte for anvendelse av dette
PT948483E (pt) Inibidores da farnesil-transferase
DE69924489D1 (de) Getreide-beta-glukanzusammensetzungen und verfahren
ID19570A (id) Metode merawat tanaman kotiledonous
EP1073333A4 (en) S-RABEPRAZOLE COMPOSITIONS AND METHODS
ATE209195T1 (de) Naphthylverbindungen und zusammensetzungen
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
ID16838A (id) Komposisi dekafluoropentana
DE69731574D1 (de) Kompiliergerät und -verfahren

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees